LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,149
تعداد مقالات10,518
تعداد مشاهده مقاله45,415,713
تعداد دریافت فایل اصل مقاله11,291,500
Torabizadeh, Camellia, Iloonkashkooli, Raziyeh, Haghshenas, Hajar, Fararouei, Mohammad. (1402). Prevalence of Cardiovascular Complications in Coronavirus Disease 2019 adult Patients: A Systematic Review and Meta-Analysis. سامانه مدیریت نشریات علمی, 48(3), 243-267. doi: 10.30476/ijms.2022.93701.2504
Camellia Torabizadeh; Raziyeh Iloonkashkooli; Hajar Haghshenas; Mohammad Fararouei. "Prevalence of Cardiovascular Complications in Coronavirus Disease 2019 adult Patients: A Systematic Review and Meta-Analysis". سامانه مدیریت نشریات علمی, 48, 3, 1402, 243-267. doi: 10.30476/ijms.2022.93701.2504
Torabizadeh, Camellia, Iloonkashkooli, Raziyeh, Haghshenas, Hajar, Fararouei, Mohammad. (1402). 'Prevalence of Cardiovascular Complications in Coronavirus Disease 2019 adult Patients: A Systematic Review and Meta-Analysis', سامانه مدیریت نشریات علمی, 48(3), pp. 243-267. doi: 10.30476/ijms.2022.93701.2504
Torabizadeh, Camellia, Iloonkashkooli, Raziyeh, Haghshenas, Hajar, Fararouei, Mohammad. Prevalence of Cardiovascular Complications in Coronavirus Disease 2019 adult Patients: A Systematic Review and Meta-Analysis. سامانه مدیریت نشریات علمی, 1402; 48(3): 243-267. doi: 10.30476/ijms.2022.93701.2504

Prevalence of Cardiovascular Complications in Coronavirus Disease 2019 adult Patients: A Systematic Review and Meta-Analysis

Iranian Journal of Medical Sciences
مقاله 3، دوره 48، شماره 3، مرداد 2023، صفحه 243-267    اصل مقاله (6.49 M)
نوع مقاله: Review Article
شناسه دیجیتال (DOI): 10.30476/ijms.2022.93701.2504
نویسندگان
Camellia Torabizadeh1؛ Raziyeh Iloonkashkooli2؛ Hajar Haghshenas* 2؛ Mohammad Fararouei3
1Community Based Psychiatric Care Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
2Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
3HIV/AIDs Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
چکیده
Background: It has been found that the new coronavirus can affect various parts of the cardiovascular system. Cardiovascular complications caused by coronavirus disease 2019 (COVID-19) are often serious and can increase the mortality rate among infected patients. This study aimed to investigate the prevalence of cardiovascular complications in COVID-19 adult patients. 
Methods: A systematic review and meta-analysis of observational studies published in English were conducted between December 2019 and February 2021. A complete search was performed in PubMed (PubMed Central and MEDLINE), Google Scholar, Cochrane Library, Science Direct, Ovid, Embase, Scopus, CINAHL, Web of Science, and WILEY, as well as BioRXiv, MedRXiv, and gray literature. A random effect model was used to examine the prevalence of cardiovascular complications among COVID-19 patients. The I2 test was used to measure heterogeneity across the included studies.
Results: A total of 74 studies involving 34,379 COVID-19 patients were included for meta-analysis. The mean age of the participants was 61.30±14.75 years. The overall pooled prevalence of cardiovascular complications was 23.45%. The most prevalent complications were acute myocardial injury (AMI) (19.38%, 95% CI=13.62-26.81, test for heterogeneity I2=97.5%, P<0.001), arrhythmia (11.16%, 95% CI=8.23-14.96, test for heterogeneity I2=91.5%, P<0.001), heart failure (HF) (7.56%, 95% CI=4.50-12.45, test for heterogeneity I2=96.3%, P<0.001), and cardiomyopathy (2.78%, 95% CI=0.34-9.68). The highest pooled prevalence of cardiac enzymes was lactate dehydrogenase (61.45%), troponin (23.10%), and creatine kinase-myocardial band or creatine kinase (14.52%).
Conclusion: The high prevalence of serious cardiovascular complications in COVID-19 patients (AMI, arrhythmia, and HF) necessitates increased awareness by healthcare administrators.
کلیدواژه‌ها
COVID-19؛ Prevalence؛ Cardiovascular System؛ Biomarkers؛ Complications
سایر فایل های مرتبط با مقاله
مراجع
  1. Velavan TP, Meyer CG. The COVID-19 epidemic. Trop Med Int Health. 2020;25:278-80. doi: 10.1111/tmi.13383. PubMed PMID: 32052514; PubMed Central PMCID: PMCPMC7169770.
  2. Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, et al. COVID-19 and Cardiovascular Disease. Circulation. 2020;141:1648-55. doi: 10.1161/CIRCULATIONAHA.120.046941. PubMed PMID: 32200663.
  3. Patel AB, Verma A. COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence? JAMA. 2020;323:1769-70. doi: 10.1001/jama.2020.4812. PubMed PMID: 32208485.
  4. Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, et al. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5:819-24. doi: 10.1001/jamacardio.2020.1096. PubMed PMID: 32219357; PubMed Central PMCID: PMCPMC7364333.
  5. Eisenhut M. Extrapulmonary manifestations of severe respiratory syncytial virus infection--a systematic review. Crit Care. 2006;10:R107. doi: 10.1186/cc4984. PubMed PMID: 16859512; PubMed Central PMCID: PMCPMC1751022.
  6. Yu CM, Wong RS, Wu EB, Kong SL, Wong J, Yip GW, et al. Cardiovascular complications of severe acute respiratory syndrome. Postgrad Med J. 2006;82:140-4. doi: 10.1136/pgmj.2005.037515. PubMed PMID: 16461478; PubMed Central PMCID: PMCPMC2596695.
  7. Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis. 2013;13:752-61. doi: 10.1016/S1473-3099(13)70204-4. PubMed PMID: 23891402; PubMed Central PMCID: PMCPMC7185445.
  8. Alhogbani T. Acute myocarditis associated with novel Middle east respiratory syndrome coronavirus. Ann Saudi Med. 2016;36:78-80. doi: 10.5144/0256-4947.2016.78. PubMed PMID: 26922692; PubMed Central PMCID: PMCPMC6074274.
  9. Saad M, Omrani AS, Baig K, Bahloul A, Elzein F, Matin MA, et al. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. Int J Infect Dis. 2014;29:301-6. doi: 10.1016/j.ijid.2014.09.003. PubMed PMID: 25303830; PubMed Central PMCID: PMCPMC7110769.
  10. Petrosillo N, Viceconte G, Ergonul O, Ippolito G, Petersen E. COVID-19, SARS and MERS: are they closely related? Clin Microbiol Infect. 2020;26:729-34. doi: 10.1016/j.cmi.2020.03.026. PubMed PMID: 32234451; PubMed Central PMCID: PMCPMC7176926.
  11. Peeri NC, Shrestha N, Rahman MS, Zaki R, Tan Z, Bibi S, et al. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Int J Epidemiol. 2020;49:717-26. doi: 10.1093/ije/dyaa033. PubMed PMID: 32086938; PubMed Central PMCID: PMCPMC7197734.
  12. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506. doi: 10.1016/S0140-6736(20)30183-5. PubMed PMID: 31986264; PubMed Central PMCID: PMCPMC7159299.
  13. Lazzerini PE, Boutjdir M, Capecchi PL. COVID-19, Arrhythmic Risk, and Inflammation: Mind the Gap! Circulation. 2020;142:7-9. doi: 10.1161/CIRCULATIONAHA.120.047293. PubMed PMID: 32286863.
  14. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17:259-60. doi: 10.1038/s41569-020-0360-5. PubMed PMID: 32139904; PubMed Central PMCID: PMCPMC7095524.
  15. Aghagoli G, Gallo Marin B, Soliman LB, Sellke FW. Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review. J Card Surg. 2020;35:1302-5. doi: 10.1111/jocs.14538. PubMed PMID: 32306491; PubMed Central PMCID: PMCPMC7264604.
  16. Mishra AK, Sahu KK, Lal A, Sargent J. Patterns of heart injury in COVID-19 and relation to outcome. J Med Virol. 2020;92:1747. doi: 10.1002/jmv.25847. PubMed PMID: 32267000; PubMed Central PMCID: PMCPMC7262038.
  17. Lange SJ, Ritchey MD, Goodman AB, Dias T, Twentyman E, Fuld J, et al. Potential Indirect Effects of the COVID-19 Pandemic on Use of Emergency Departments for Acute Life-Threatening Conditions - United States, January-May 2020. MMWR Morb Mortal Wkly Rep. 2020;69:795-800. doi: 10.15585/mmwr.mm6925e2. PubMed PMID: 32584802; PubMed Central PMCID: PMCPMC7316316.
  18. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323:1061-9. doi: 10.1001/jama.2020.1585. PubMed PMID: 32031570; PubMed Central PMCID: PMCPMC7042881.
  19. Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl). 2020;133:1025-31. doi: 10.1097/CM9.0000000000000744. PubMed PMID: 32044814; PubMed Central PMCID: PMCPMC7147277.
  20. Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, et al. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA. 2020;323:1406-7. doi: 10.1001/jama.2020.2565. PubMed PMID: 32083643; PubMed Central PMCID: PMCPMC7042844.
  21. Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091. doi: 10.1136/bmj.m1091. PubMed PMID: 32217556; PubMed Central PMCID: PMCPMC7190011.
  22. Strabelli TMV, Uip DE. COVID-19 and the Heart. Arq Bras Cardiol. 2020;114:598-600. doi: 10.36660/abc.20200209. PubMed PMID: 32236325.
  23. Deng P, Ke Z, Ying B, Qiao B, Yuan L. The diagnostic and prognostic role of myocardial injury biomarkers in hospitalized patients with COVID-19. Clin Chim Acta. 2020;510:186-90. doi: 10.1016/j.cca.2020.07.018. PubMed PMID: 32681933; PubMed Central PMCID: PMCPMC7363604.
  24. Shah P, Doshi R, Chenna A, Owens R, Cobb A, Ivey H, et al. Prognostic Value of Elevated Cardiac Troponin I in Hospitalized Covid-19 Patients. Am J Cardiol. 2020;135:150-3. doi: 10.1016/j.amjcard.2020.08.041. PubMed PMID: 32861733; PubMed Central PMCID: PMCPMC7452835.
  25. Parohan M, Yaghoubi S, Seraji A. Cardiac injury is associated with severe outcome and death in patients with Coronavirus disease 2019 (COVID-19) infection: A systematic review and meta-analysis of observational studies. Eur Heart J Acute Cardiovasc Care. 2020;9:665-77. doi: 10.1177/2048872620937165. PubMed PMID: 32567326; PubMed Central PMCID: PMCPMC7678334.
  26. Xie J, Wu W, Li S, Hu Y, Hu M, Li J, et al. Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study. Intensive Care Med. 2020;46:1863-72. doi: 10.1007/s00134-020-06211-2. PubMed PMID: 32816098; PubMed Central PMCID: PMCPMC7439240.
  27. Wang K, Qiu Z, Liu J, Fan T, Liu C, Tian P, et al. Analysis of the clinical characteristics of 77 COVID-19 deaths. Sci Rep. 2020;10:16384. doi: 10.1038/s41598-020-73136-7. PubMed PMID: 33009426; PubMed Central PMCID: PMCPMC7532142.
  28. Suleyman G, Fadel RA, Malette KM, Hammond C, Abdulla H, Entz A, et al. Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit. JAMA Netw Open. 2020;3:e2012270. doi: 10.1001/jamanetworkopen.2020.12270. PubMed PMID: 32543702; PubMed Central PMCID: PMCPMC7298606.
  29. Sahranavard M, Akhavan Rezayat A, Zamiri Bidary M, Omranzadeh A, Rohani F, Hamidi Farahani R, et al. Cardiac Complications in COVID-19: A Systematic Review and Meta-analysis. Arch Iran Med. 2021;24:152-63. doi: 10.34172/aim.2021.24. PubMed PMID: 33636985.
  30. Wang L, He W, Yu X, Hu D, Bao M, Liu H, et al. Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up. J Infect. 2020;80:639-45. doi: 10.1016/j.jinf.2020.03.019. PubMed PMID: 32240670; PubMed Central PMCID: PMCPMC7118526.
  31. Kim IC, Kim JY, Kim HA, Han S. COVID-19-related myocarditis in a 21-year-old female patient. Eur Heart J. 2020;41:1859. doi: 10.1093/eurheartj/ehaa288. PubMed PMID: 32282027; PubMed Central PMCID: PMCPMC7184491.
  32. Ma K-L, Liu Z-H, Cao C-f, Liu M-K, Liao J, Zou J-B, et al. COVID-19 myocarditis and severity factors: an adult cohort study. MedRxiv. 2020;48:773-7. doi: 10.1101/2020.03.19.20034124.
  33. Zeng JH, Liu YX, Yuan J, Wang FX, Wu WB, Li JX, et al. First case of COVID-19 complicated with fulminant myocarditis: a case report and insights. Infection. 2020;48:773-7. doi: 10.1007/s15010-020-01424-5. PubMed PMID: 32277408; PubMed Central PMCID: PMCPMC7146072.
  34. Sala S, Peretto G, Gramegna M, Palmisano A, Villatore A, Vignale D, et al. Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection. Eur Heart J. 2020;41:1861-2. doi: 10.1093/eurheartj/ehaa286. PubMed PMID: 32267502; PubMed Central PMCID: PMCPMC7184339.
  35. Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin. Eur Heart J. 2021;42:206. doi: 10.1093/eurheartj/ehaa190. PubMed PMID: 32176300; PubMed Central PMCID: PMCPMC7184348.
  36. Edler C, Schroder AS, Aepfelbacher M, Fitzek A, Heinemann A, Heinrich F, et al. Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany. Int J Legal Med. 2020;134:1275-84. doi: 10.1007/s00414-020-02317-w. PubMed PMID: 32500199; PubMed Central PMCID: PMCPMC7271136.
  37. Hua A, O’Gallagher K, Sado D, Byrne J. Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19. Eur Heart J. 2020;41:2130. doi: 10.1093/eurheartj/ehaa253. PubMed PMID: 32227076; PubMed Central PMCID: PMCPMC7184427.
  38. Hong KS, Lee KH, Chung JH, Shin KC, Choi EY, Jin HJ, et al. Clinical Features and Outcomes of 98 Patients Hospitalized with SARS-CoV-2 Infection in Daegu, South Korea: A Brief Descriptive Study. Yonsei Med J. 2020;61:431-7. doi: 10.3349/ymj.2020.61.5.431. PubMed PMID: 32390367; PubMed Central PMCID: PMCPMC7214108.
  39. Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, et al. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA. 2020;323:1612-4. doi: 10.1001/jama.2020.4326. PubMed PMID: 32191259; PubMed Central PMCID: PMCPMC7082763.
  40. Zheng Y, Sun LJ, Xu M, Pan J, Zhang YT, Fang XL, et al. Clinical characteristics of 34 COVID-19 patients admitted to intensive care unit in Hangzhou, China. J Zhejiang Univ Sci B. 2020;21:378-87. doi: 10.1631/jzus.B2000174. PubMed PMID: 32425003; PubMed Central PMCID: PMCPMC7238397.
  41. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-62. doi: 10.1016/S0140-6736(20)30566-3. PubMed PMID: 32171076; PubMed Central PMCID: PMCPMC7270627.
  42. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1. doi: 10.1186/2046-4053-4-1. PubMed PMID: 25554246; PubMed Central PMCID: PMCPMC4320440.
  43. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507-13. doi: 10.1016/S0140-6736(20)30211-7. PubMed PMID: 32007143; PubMed Central PMCID: PMCPMC7135076.
  44. Zhang B, Zhou X, Qiu Y, Song Y, Feng F, Feng J, et al. Clinical characteristics of 82 cases of death from COVID-19. PLoS One. 2020;15:e0235458. doi: 10.1371/journal.pone.0235458. PubMed PMID: 32645044; PubMed Central PMCID: PMCPMC7347130.
  45. Liu Y, Li J, Liu D, Song H, Chen C, Lv M, et al. Clinical features and outcomes of 2019 novel coronavirus–infected patients with cardiac injury. MedRxiv. 2020. doi: 10.1101/2020.03.11.20030957.
  46. Hui H, Zhang Y, Yang X, Wang X, He B, Li L, et al. Clinical and radiographic features of cardiac injury in patients with 2019 novel coronavirus pneumonia. MedRxiv. 2020. doi: 10.1101/2020.02.24.20027052.
  47. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8:475-81. doi: 10.1016/S2213-2600(20)30079-5. PubMed PMID: 32105632; PubMed Central PMCID: PMCPMC7102538.
  48. Wei JF, Huang FY, Xiong TY, Liu Q, Chen H, Wang H, et al. Acute myocardial injury is common in patients with COVID-19 and impairs their prognosis. Heart. 2020;106:1154-9. doi: 10.1136/heartjnl-2020-317007. PubMed PMID: 32354798; PubMed Central PMCID: PMCPMC7398466.
  49. Shi S, Qin M, Cai Y, Liu T, Shen B, Yang F, et al. Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019. Eur Heart J. 2020;41:2070-9. doi: 10.1093/eurheartj/ehaa408. PubMed PMID: 32391877; PubMed Central PMCID: PMCPMC7239100.
  50. Zhang G, Hu C, Luo L, Fang F, Chen Y, Li J, et al. Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China. J Clin Virol. 2020;127:104364. doi: 10.1016/j.jcv.2020.104364. PubMed PMID: 32311650; PubMed Central PMCID: PMCPMC7194884 conflicts of interest.
  51. Wan S, Xiang Y, Fang W, Zheng Y, Li B, Hu Y, et al. Clinical features and treatment of COVID-19 patients in northeast Chongqing. J Med Virol. 2020;92:797-806. doi: 10.1002/jmv.25783. PubMed PMID: 32198776; PubMed Central PMCID: PMCPMC7228368.
  52. Zhang J, Liu P, Wang M, Wang J, Chen J, Yuan W, et al. The clinical data from 19 critically ill patients with coronavirus disease 2019: a single-centered, retrospective, observational study. Z Gesundh Wiss. 2022;30:361-4. doi: 10.1007/s10389-020-01291-2. PubMed PMID: 32318325; PubMed Central PMCID: PMCPMC7171052.
  53. Li Y, Hu Y, Yu J, Ma T. Retrospective analysis of laboratory testing in 54 patients with severe- or critical-type 2019 novel coronavirus pneumonia. Lab Invest. 2020;100:794-800. doi: 10.1038/s41374-020-0431-6. PubMed PMID: 32341519; PubMed Central PMCID: PMCPMC7184820.
  54. Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802-10. doi: 10.1001/jamacardio.2020.0950. PubMed PMID: 32211816; PubMed Central PMCID: PMCPMC7097841.
  55. Aggarwal S, Garcia-Telles N, Aggarwal G, Lavie C, Lippi G, Henry BM. Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): Early report from the United States. Diagnosis (Berl). 2020;7:91-6. doi: 10.1515/dx-2020-0046. PubMed PMID: 32352401.
  56. Yang A, Qiu Q, Kong X, Sun Y, Chen T, Zuo Y, et al. Clinical and Epidemiological Characteristics of COVID-19 Patients in Chongqing China. Front Public Health. 2020;8:244. doi: 10.3389/fpubh.2020.00244. PubMed PMID: 32574309; PubMed Central PMCID: PMCPMC7273918.
  57. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020;323:2052-9. doi: 10.1001/jama.2020.6775. PubMed PMID: 32320003; PubMed Central PMCID: PMCPMC7177629.
  58. Feng Y, Ling Y, Bai T, Xie Y, Huang J, Li J, et al. COVID-19 with Different Severities: A Multicenter Study of Clinical Features. Am J Respir Crit Care Med. 2020;201:1380-8. doi: 10.1164/rccm.202002-0445OC. PubMed PMID: 32275452; PubMed Central PMCID: PMCPMC7258639.
  59. Yang L, Liu J, Zhang R, Li M, Li Z, Zhou X, et al. Epidemiological and clinical features of 200 hospitalized patients with corona virus disease 2019 outside Wuhan, China: A descriptive study. J Clin Virol. 2020;129:104475. doi: 10.1016/j.jcv.2020.104475. PubMed PMID: 32485619; PubMed Central PMCID: PMCPMC7250074.
  60. Jin L, Tang W, Song L, Luo L, Zhou Z, Fan X, et al. Acute cardiac injury in adult hospitalized COVID-19 patients in Zhuhai, China. Cardiovasc Diagn Ther. 2020;10:1303-12. doi: 10.21037/cdt-20-607. PubMed PMID: 33224754; PubMed Central PMCID: PMCPMC7666934.
  61. Liu J, Zhang L, Chen Y, Wu Z, Dong X, Teboul JL, et al. Association of sex with clinical outcomes in COVID-19 patients: A retrospective analysis of 1190 cases. Respir Med. 2020;173:106159. doi: 10.1016/j.rmed.2020.106159. PubMed PMID: 33010731; PubMed Central PMCID: PMCPMC7521447.
  62. Lombardi CM, Carubelli V, Iorio A, Inciardi RM, Bellasi A, Canale C, et al. Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019: Results of a Multicenter Study. JAMA Cardiol. 2020;5:1274-80. doi: 10.1001/jamacardio.2020.3538. PubMed PMID: 32845276; PubMed Central PMCID: PMCPMC7450398.
  63. Li J, Zhang Y, Wang F, Liu B, Li H, Tang G, et al. Cardiac damage in patients with the severe type of coronavirus disease 2019 (COVID-19). BMC Cardiovasc Disord. 2020;20:479. doi: 10.1186/s12872-020-01758-w. PubMed PMID: 33167876; PubMed Central PMCID: PMCPMC7652577.
  64. Ghio S, Baldi E, Vicentini A, Lenti MV, Di Sabatino A, Di Matteo A, et al. Correction to: Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy. Intern Emerg Med. 2021;16:807. doi: 10.1007/s11739-020-02604-9. PubMed PMID: 33475974; PubMed Central PMCID: PMCPMC7817763.
  65. Lazzeri C, Bonizzoli M, Batacchi S, Cianchi G, Franci A, Fulceri GE, et al. Cardiac Involvment in COVID-19-Related Acute Respiratory Distress Syndrome. Am J Cardiol. 2020;132:147-9. doi: 10.1016/j.amjcard.2020.07.010. PubMed PMID: 32762961; PubMed Central PMCID: PMCPMC7355325.
  66. Fan H, Zhang L, Huang B, Zhu M, Zhou Y, Zhang H, et al. Cardiac injuries in patients with coronavirus disease 2019: Not to be ignored. Int J Infect Dis. 2020;96:294-7. doi: 10.1016/j.ijid.2020.05.024. PubMed PMID: 32437935; PubMed Central PMCID: PMCPMC7211636.
  67. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5:811-8. doi: 10.1001/jamacardio.2020.1017. PubMed PMID: 32219356; PubMed Central PMCID: PMCPMC7101506.
  68. Ferguson J, Rosser JI, Quintero O, Scott J, Subramanian A, Gumma M, et al. Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020. Emerg Infect Dis. 2020;26:1679-85. doi: 10.3201/eid2608.201776. PubMed PMID: 32407284; PubMed Central PMCID: PMCPMC7392471.
  69. Abrams MP, Wan EY, Waase MP, Morrow JP, Dizon JM, Yarmohammadi H, et al. Clinical and cardiac characteristics of COVID-19 mortalities in a diverse New York City Cohort. J Cardiovasc Electrophysiol. 2020;31:3086-96. doi: 10.1111/jce.14772. PubMed PMID: 33022765; PubMed Central PMCID: PMCPMC7675758.
  70. Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130:2620-9. doi: 10.1172/JCI137244. PubMed PMID: 32217835; PubMed Central PMCID: PMCPMC7190990.
  71. Russo V, Di Maio M, Mottola FF, Pagnano G, Attena E, Verde N, et al. Clinical characteristics and prognosis of hospitalized COVID-19 patients with incident sustained tachyarrhythmias: A multicenter observational study. Eur J Clin Invest. 2020;50:e13387. doi: 10.1111/eci.13387. PubMed PMID: 32813877; PubMed Central PMCID: PMCPMC7460920.
  72. Xiong S, Liu L, Lin F, Shi J, Han L, Liu H, et al. Clinical characteristics of 116 hospitalized patients with COVID-19 in Wuhan, China: a single-centered, retrospective, observational study. BMC Infect Dis. 2020;20:787. doi: 10.1186/s12879-020-05452-2. PubMed PMID: 33092539; PubMed Central PMCID: PMCPMC7578439.
  73. Li T, Lu L, Zhang W, Tao Y, Wang L, Bao J, et al. Clinical characteristics of 312 hospitalized older patients with COVID-19 in Wuhan, China. Arch Gerontol Geriatr. 2020;91:104185. doi: 10.1016/j.archger.2020.104185. PubMed PMID: 32688107; PubMed Central PMCID: PMCPMC7361038.
  74. Guo T, Shen Q, Guo W, He W, Li J, Zhang Y, et al. Clinical Characteristics of Elderly Patients with COVID-19 in Hunan Province, China: A Multicenter, Retrospective Study. Gerontology. 2020;66:467-75. doi: 10.1159/000508734. PubMed PMID: 32474561.
  75. He F, Quan Y, Lei M, Liu R, Qin S, Zeng J, et al. Clinical features and risk factors for ICU admission in COVID-19 patients with cardiovascular diseases. Aging Dis. 2020;11:763-9. doi: 10.14336/AD.2020.0622. PubMed PMID: 32765943; PubMed Central PMCID: PMCPMC7390529.
  76. Li P, Chen L, Liu Z, Pan J, Zhou D, Wang H, et al. Clinical features and short-term outcomes of elderly patients with COVID-19. Int J Infect Dis. 2020;97:245-50. doi: 10.1016/j.ijid.2020.05.107. PubMed PMID: 32492533; PubMed Central PMCID: PMCPMC7261456.
  77. Du Y, Tu L, Zhu P, Mu M, Wang R, Yang P, et al. Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study. Am J Respir Crit Care Med. 2020;201:1372-9. doi: 10.1164/rccm.202003-0543OC. PubMed PMID: 32242738; PubMed Central PMCID: PMCPMC7258652.
  78. Huang R, Zhu L, Xue L, Liu L, Yan X, Wang J, et al. Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: A retrospective, multi-center study. PLoS Negl Trop Dis. 2020;14:e0008280. doi: 10.1371/journal.pntd.0008280. PubMed PMID: 32384078; PubMed Central PMCID: PMCPMC7239492.
  79. Li X, Wang L, Yan S, Yang F, Xiang L, Zhu J, et al. Clinical characteristics of 25 death cases with COVID-19: A retrospective review of medical records in a single medical center, Wuhan, China. Int J Infect Dis. 2020;94:128-32. doi: 10.1016/j.ijid.2020.03.053. PubMed PMID: 32251805; PubMed Central PMCID: PMCPMC7128884.
  80. Palmieri L, Vanacore N, Donfrancesco C, Lo Noce C, Canevelli M, Punzo O, et al. Clinical Characteristics of Hospitalized Individuals Dying With COVID-19 by Age Group in Italy. J Gerontol A Biol Sci Med Sci. 2020;75:1796-800. doi: 10.1093/gerona/glaa146. PubMed PMID: 32506122; PubMed Central PMCID: PMCPMC7314182.
  81. Mughal MS, Kaur IP, Jaffery AR, Dalmacion DL, Wang C, Koyoda S, et al. COVID-19 patients in a tertiary US hospital: Assessment of clinical course and predictors of the disease severity. Respir Med. 2020;172:106130. doi: 10.1016/j.rmed.2020.106130. PubMed PMID: 32896798; PubMed Central PMCID: PMCPMC7455149.
  82. Wang ZH, Shu C, Ran X, Xie CH, Zhang L. Critically Ill Patients with Coronavirus Disease 2019 in a Designated ICU: Clinical Features and Predictors for Mortality. Risk Manag Healthc Policy. 2020;13:833-45. doi: 10.2147/RMHP.S263095. PubMed PMID: 32765138; PubMed Central PMCID: PMCPMC7381092.
  83. Stefanini GG, Chiarito M, Ferrante G, Cannata F, Azzolini E, Viggiani G, et al. Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19. Heart. 2020;106:1512-8. doi: 10.1136/heartjnl-2020-317322. PubMed PMID: 32817312.
  84. Wang Y, Chen L, Wang J, He X, Huang F, Chen J, et al. Electrocardiogram analysis of patients with different types of COVID-19. Ann Noninvasive Electrocardiol. 2020;25:e12806. doi: 10.1111/anec.12806. PubMed PMID: 32951316; PubMed Central PMCID: PMCPMC7536962.
  85. Heberto AB, Carlos PCJ, Antonio CRJ, Patricia PP, Enrique TR, Danira MPJ, et al. Implications of myocardial injury in Mexican hospitalized patients with coronavirus disease 2019 (COVID-19). Int J Cardiol Heart Vasc. 2020;30:100638. doi: 10.1016/j.ijcha.2020.100638. PubMed PMID: 32953968; PubMed Central PMCID: PMCPMC7486879.
  86. Li C, Jiang J, Wang F, Zhou N, Veronese G, Moslehi JJ, et al. Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients. J Mol Cell Cardiol. 2020;147:74-87. doi: 10.1016/j.yjmcc.2020.08.008. PubMed PMID: 32827510; PubMed Central PMCID: PMCPMC7438272.
  87. Cao J, Zheng Y, Luo Z, Mei Z, Yao Y, Liu Z, et al. Myocardial injury and COVID-19: Serum hs-cTnI level in risk stratification and the prediction of 30-day fatality in COVID-19 patients with no prior cardiovascular disease. Theranostics. 2020;10:9663-73. doi: 10.7150/thno.47980. PubMed PMID: 32863952; PubMed Central PMCID: PMCPMC7449913.
  88. Lorente-Ros A, Monteagudo Ruiz JM, Rincon LM, Ortega Perez R, Rivas S, Martinez-Moya R, et al. Myocardial injury determination improves risk stratification and predicts mortality in COVID-19 patients. Cardiol J. 2020;27:489-96. doi: 10.5603/CJ.a2020.0089. PubMed PMID: 32589258; PubMed Central PMCID: PMCPMC8078990.
  89. Yang C, Liu F, Liu W, Cao G, Liu J, Huang S, et al. Myocardial injury and risk factors for mortality in patients with COVID-19 pneumonia. Int J Cardiol. 2021;326:230-6. doi: 10.1016/j.ijcard.2020.09.048. PubMed PMID: 32979425; PubMed Central PMCID: PMCPMC7510443.
  90. Qian H, Gao P, Tian R, Yang X, Guo F, Li T, et al. Myocardial Injury on Admission as a Risk in Critically Ill COVID-19 Patients: A Retrospective in-ICU Study. J Cardiothorac Vasc Anesth. 2021;35:846-53. doi: 10.1053/j.jvca.2020.10.019. PubMed PMID: 33162306; PubMed Central PMCID: PMCPMC7566673.
  91. Zhao S, Lin Y, Zhou C, Wang L, Chen X, Clifford SP, et al. Short-Term Outcomes of Patients With COVID-19 Undergoing Invasive Mechanical Ventilation: A Retrospective Observational Study From Wuhan, China. Front Med (Lausanne). 2020;7:571542. doi: 10.3389/fmed.2020.571542. PubMed PMID: 33117833; PubMed Central PMCID: PMCPMC7553072.
  92. Chen FF, Zhong M, Liu Y, Zhang Y, Zhang K, Su DZ, et al. The characteristics and outcomes of 681 severe cases with COVID-19 in China. J Crit Care. 2020;60:32-7. doi: 10.1016/j.jcrc.2020.07.003. PubMed PMID: 32736197; PubMed Central PMCID: PMCPMC7340593.
  93. Lala A, Johnson KW, Januzzi JL, Russak AJ, Paranjpe I, Richter F, et al. Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection. J Am Coll Cardiol. 2020;76:533-46. doi: 10.1016/j.jacc.2020.06.007. PubMed PMID: 32517963; PubMed Central PMCID: PMCPMC7279721.
  94. Karbalai Saleh S, Oraii A, Soleimani A, Hadadi A, Shajari Z, Montazeri M, et al. The association between cardiac injury and outcomes in hospitalized patients with COVID-19. Intern Emerg Med. 2020;15:1415-24. doi: 10.1007/s11739-020-02466-1. PubMed PMID: 32772283; PubMed Central PMCID: PMCPMC7415198.
  95. Xu H, Hou K, Xu H, Li Z, Chen H, Zhang N, et al. Acute myocardial injury of patients with coronavirus disease 2019. MedRxiv. 2020. doi: 10.1101/2020.03.05.20031591.
  96. Argenziano MG, Bruce SL, Slater CL, Tiao JR, Baldwin MR, Barr RG, et al. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series. BMJ. 2020;369:m1996. doi: 10.1136/bmj.m1996. PubMed PMID: 32471884; PubMed Central PMCID: PMCPMC7256651
  97. Linschoten M, Peters S, van Smeden M, Jewbali LS, Schaap J, Siebelink HM, et al. Cardiac complications in patients hospitalised with COVID-19. Eur Heart J Acute Cardiovasc Care. 2020;9:817-23. doi: 10.1177/2048872620974605. PubMed PMID: 33222494; PubMed Central PMCID: PMCPMC7734244.
  98. Saleh A, Matsumori A, Abdelrazek S, Eltaweel S, Salous A, Neumann FJ, et al. Myocardial involvement in coronavirus disease 19. Herz. 2020;45:719-25. doi: 10.1007/s00059-020-05001-2. PubMed PMID: 33216154; PubMed Central PMCID: PMCPMC7677904.
  99. Papageorgiou N, Providencia R, Saberwal B, Sohrabi C, Tyrlis A, Atieh AE, et al. Ethnicity and COVID-19 cardiovascular complications: a multi-center UK cohort. Am J Cardiovasc Dis. 2020;10:455-62. PubMed PMID: 33224596; PubMed Central PMCID: PMCPMC7675148.
  100. Becerra-Munoz VM, Nunez-Gil IJ, Eid CM, Garcia Aguado M, Romero R, Huang J, et al. Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19. Age Ageing. 2021;50:326-34. doi: 10.1093/ageing/afaa258. PubMed PMID: 33201181; PubMed Central PMCID: PMCPMC7717146.
  101. Yan X, Wang S, Ma P, Yang B, Si D, Liu G, et al. Cardiac injury is associated with inflammation in geriatric COVID-19 patients. J Clin Lab Anal. 2021;35:e23654. doi: 10.1002/jcla.23654. PubMed PMID: 33210392; PubMed Central PMCID: PMCPMC7744922.
  102. Arcari L, Luciani M, Cacciotti L, Musumeci MB, Spuntarelli V, Pistella E, et al. Incidence and determinants of high-sensitivity troponin and natriuretic peptides elevation at admission in hospitalized COVID-19 pneumonia patients. Intern Emerg Med. 2020;15:1467-76. doi: 10.1007/s11739-020-02498-7. PubMed PMID: 32986136; PubMed Central PMCID: PMCPMC7520380.
  103. Chan JW, Ng CK, Chan YH, Mok TY, Lee S, Chu SY, et al. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax. 2003;58:686-9. doi: 10.1136/thorax.58.8.686. PubMed PMID: 12885985; PubMed Central PMCID: PMCPMC1746764.
  104. Deng G, Yin M, Chen X, Zeng F. Clinical determinants for fatality of 44,672 patients with COVID-19. Crit Care. 2020;24:179. doi: 10.1186/s13054-020-02902-w. PubMed PMID: 32345311; PubMed Central PMCID: PMCPMC7187660.
  105. Lippi G, Wong J, Henry BM. Hypertension in patients with coronavirus disease 2019 (COVID-19): a pooled analysis. Pol Arch Intern Med. 2020;130:304-9. doi: 10.20452/pamw.15272. PubMed PMID: 32231171.
  106. Chen Y, Gong X, Wang L, Guo J. Effects of hypertension, diabetes and coronary heart disease on COVID-19 diseases severity: a systematic review and meta-analysis. MedRxiv. 2020. doi: 10.1101/2020.03.25.20043133.
  107. Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis. Arch Acad Emerg Med. 2020;8:e35. PubMed PMID: 32232218; PubMed Central PMCID: PMCPMC7096724.
  108. Schiffrin EL, Flack JM, Ito S, Muntner P, Webb RC. Hypertension and COVID-19. Am J Hypertens. 2020;33:373-4. doi: 10.1093/ajh/hpaa057. PubMed PMID: 32251498; PubMed Central PMCID: PMCPMC7184512.
  109. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020;180:934-43. doi: 10.1001/jamainternmed.2020.0994. PubMed PMID: 32167524; PubMed Central PMCID: PMCPMC7070509.
  110. Momtazmanesh S, Shobeiri P, Hanaei S, Mahmoud-Elsayed H, Dalvi B, Malakan Rad E. Cardiovascular disease in COVID-19: a systematic review and meta-analysis of 10,898 patients and proposal of a triage risk stratification tool. Egypt Heart J. 2020;72:41. doi: 10.1186/s43044-020-00075-z. PubMed PMID: 32661796; PubMed Central PMCID: PMCPMC7356124.
  111. Zou F, Qian Z, Wang Y, Zhao Y, Bai J. Cardiac Injury and COVID-19: A Systematic Review and Meta-analysis. CJC Open. 2020;2:386-94. doi: 10.1016/j.cjco.2020.06.010. PubMed PMID: 32838255; PubMed Central PMCID: PMCPMC7308771.
  112. Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97:829-38. doi: 10.1016/j.kint.2020.03.005. PubMed PMID: 32247631; PubMed Central PMCID: PMCPMC7110296.
  113. Tomasoni D, Italia L, Adamo M, Inciardi RM, Lombardi CM, Solomon SD, et al. COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease. Eur J Heart Fail. 2020;22:957-66. doi: 10.1002/ejhf.1871. PubMed PMID: 32412156; PubMed Central PMCID: PMCPMC7273093.
  114. South AM, Diz DI, Chappell MC. COVID-19, ACE2, and the cardiovascular consequences. Am J Physiol Heart Circ Physiol. 2020;318:H1084-H90. doi: 10.1152/ajpheart.00217.2020. PubMed PMID: 32228252; PubMed Central PMCID: PMCPMC7191628.
  115. Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109:531-8. doi: 10.1007/s00392-020-01626-9. PubMed PMID: 32161990; PubMed Central PMCID: PMCPMC7087935.
  116. Pellicori P, Doolub G, Wong CM, Lee KS, Mangion K, Ahmad M, et al. COVID-19 and its cardiovascular effects: a systematic review of prevalence studies. Cochrane Database Syst Rev. 2021;3:CD013879. doi: 10.1002/14651858.CD013879. PubMed PMID: 33704775; PubMed Central PMCID: PMCPMC8078349.
  117. Bhatla A, Mayer MM, Adusumalli S, Hyman MC, Oh E, Tierney A, et al. COVID-19 and cardiac arrhythmias. Heart Rhythm. 2020;17:1439-44. doi: 10.1016/j.hrthm.2020.06.016. PubMed PMID: 32585191; PubMed Central PMCID: PMCPMC7307518.
  118. Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G. Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19. N Engl J Med. 2020;382:2431-40. doi: 10.1056/NEJMoa2006923. PubMed PMID: 32356627; PubMed Central PMCID: PMCPMC7206933.
  119. Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, et al. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. J Am Coll Cardiol. 2020;75:2352-71. doi: 10.1016/j.jacc.2020.03.031. PubMed PMID: 32201335; PubMed Central PMCID: PMCPMC7198856.
  120. Oudit GY, Kassiri Z, Jiang C, Liu PP, Poutanen SM, Penninger JM, et al. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest. 2009;39:618-25. doi: 10.1111/j.1365-2362.2009.02153.x. PubMed PMID: 19453650; PubMed Central PMCID: PMCPMC7163766.
  121. Li X, Pan X, Li Y, An N, Xing Y, Yang F, et al. Cardiac injury associated with severe disease or ICU admission and death in hospitalized patients with COVID-19: a meta-analysis and systematic review. Crit Care. 2020;24:468. doi: 10.1186/s13054-020-03183-z. PubMed PMID: 32723362; PubMed Central PMCID: PMCPMC7386170.
  122. Chen C, Chen C, Yan JT, Zhou N, Zhao JP, Wang DW. [Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19]. Zhonghua Xin Xue Guan Bing Za Zhi. 2020;48:567-71. doi: 10.3760/cma.j.cn112148-20200225-00123. PubMed PMID: 32141280.
  123. Wang JT, Sheng WH, Fang CT, Chen YC, Wang JL, Yu CJ, et al. Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients. Emerg Infect Dis. 2004;10:818-24. doi: 10.3201/eid1005.030640. PubMed PMID: 15200814; PubMed Central PMCID: PMCPMC3323212.
  124. Welt FGP, Shah PB, Aronow HD, Bortnick AE, Henry TD, Sherwood MW, et al. Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From the ACC’s Interventional Council and SCAI. J Am Coll Cardiol. 2020;75:2372-5. doi: 10.1016/j.jacc.2020.03.021. PubMed PMID: 32199938; PubMed Central PMCID: PMCPMC7270593.
  125. Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361:1767-72. doi: 10.1016/s0140-6736(03)13412-5. PubMed PMID: 12781535; PubMed Central PMCID: PMCPMC7112410.
  126. Cooper LT, Jr. Myocarditis. N Engl J Med. 2009;360:1526-38. doi: 10.1056/NEJMra0800028. PubMed PMID: 19357408; PubMed Central PMCID: PMCPMC5814110.
  127. Nicholson KG, Webster RG, Hay AJ. Textbook of influenza. New Jersey: Blackwell Science Ltd; 1998.
  128. Daniels CJ, Rajpal S, Greenshields JT, Rosenthal GL, Chung EH, Terrin M, et al. Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection: Results From the Big Ten COVID-19 Cardiac Registry. JAMA Cardiol. 2021;6:1078-87. doi: 10.1001/jamacardio.2021.2065. PubMed PMID: 34042947; PubMed Central PMCID: PMCPMC8160916.
  129. Vasudevan G, Mercer DW, Varat MA. Lactic dehydrogenase isoenzyme determination in the diagnosis of acute myocardial infarction. Circulation. 1978;57:1055-7. doi: 10.1161/01.cir.57.6.1055. PubMed PMID: 639224.
  130. Ndrepepa G, Kastrati A. Creatine kinase myocardial band - a biomarker to assess prognostically relevant periprocedural myocardial infarction. Int J Cardiol. 2018;270:118-9. doi: 10.1016/j.ijcard.2018.07.077. PubMed PMID: 30054147.
  131. O’Brien PJ. Cardiac troponin is the most effective translational safety biomarker for myocardial injury in cardiotoxicity. Toxicology. 2008;245:206-18. doi: 10.1016/j.tox.2007.12.006. PubMed PMID: 18249481.
  132. Aydin S, Ugur K, Aydin S, Sahin I, Yardim M. Biomarkers in acute myocardial infarction: current perspectives. Vasc Health Risk Manag. 2019;15:1-10. doi: 10.2147/VHRM.S166157. PubMed PMID: 30697054; PubMed Central PMCID: PMCPMC6340361.
  133. Heinova D, Rosival I, Avidar Y, Bogin E. Lactate dehydrogenase isoenzyme distribution and patterns in chicken organs. Res Vet Sci. 1999;67:309-12. doi: 10.1053/rvsc.1999.0317. PubMed PMID: 10607514.
آمار
تعداد مشاهده مقاله: 1,180
تعداد دریافت فایل اصل مقاله: 804


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب